Cellular Biomedicine Group, Inc. develops proprietary cell therapies for the treatment of cancer and degenerative diseases. The company conducts immuno-oncology and stem cell clinical trials in China using products from its integrated GMP laboratory.

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards. For more information, please visit www.cellbiomedgroup.com.

Sailing Capital

Wuhan Dangdai Science & Technology Industries Group

YF Capital

COM:CELLBIOMEDGROUP

Cellular Biomedicine Group, Inc.

Analysis Not Available